Feng Di, DuMontier Clark, Pollak Martin R
Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215 USA.
Department of Medicine, Boston University School of Medicine, Boston, MA 02118 USA.
Cell Biosci. 2015 Aug 18;5:44. doi: 10.1186/s13578-015-0036-8. eCollection 2015.
Mutations in the Alpha-actinin-4 gene (ACTN4) cause a rare form of familial focal segmental glomerulosclerosis in humans. Individuals with kidney disease-associated ACTN4 mutations tend to have mild to moderate proteinuria, with many developing decreased kidney function progressing to end stage kidney disease. All of the disease-causing ACTN4 mutations identified to date are located within the actin-binding domain of the encoded protein, increasing its binding affinity to F-actin and leading to abnormal actin rich cellular aggregates. The identification of ACTN4 mutations as a cause of human kidney disease demonstrates a key cellular pathway by which alterations in cytoskeletal behavior can mediate kidney disease. Here we review the studies relevant to ACTN4 and its role in mediating kidney disease.
α-辅肌动蛋白4基因(ACTN4)的突变会导致人类一种罕见的家族性局灶节段性肾小球硬化症。患有与肾脏疾病相关的ACTN4突变的个体往往有轻度至中度蛋白尿,许多人会出现肾功能下降,进而发展为终末期肾病。迄今为止鉴定出的所有致病ACTN4突变都位于编码蛋白的肌动蛋白结合域内,增加了其与F-肌动蛋白的结合亲和力,并导致富含肌动蛋白的异常细胞聚集体。ACTN4突变作为人类肾脏疾病的一个病因的鉴定,揭示了细胞骨架行为改变可介导肾脏疾病的关键细胞途径。在此,我们综述了与ACTN4及其在介导肾脏疾病中的作用相关的研究。